Lack of sleep may increase risk for diabetes, say CU Anschutz, CU-Boulder researchers

November 05, 2015

AURORA, Colo. (Nov. 5, 2015) - A lack of sufficient sleep reduces the body's sensitivity to insulin, impairing the ability to regulate blood sugar and increasing the risk of diabetes, according to researchers from the University of Colorado Anschutz Medical Campus and the University of Colorado Boulder.

The new study adds to a growing body of information linking a lack of sleep to a range of ailments including obesity, metabolic syndrome, mood disorders, cognitive impairment and accidents.

"We found that when people get too little sleep it leaves them awake at a time when their body clock is telling them they should be asleep," said the study's lead author Kenneth Wright Jr., PhD, professor of integrative physiology at CU-Boulder and also professor of medicine at the University of Colorado School of Medicine. "And when they eat something in the morning, it impairs their ability to regulate their blood sugar levels."

Wright and co-author Robert Eckel, MD, an endocrinologist and professor of medicine at CU Anschutz, looked at 16 healthy men and women in their study.

Half of the test subjects initially slept for up to five hours a night for five days to simulate a regular work week.

Then they slept for up to nine hours a night for five days. The other half completed the sleep conditions in the opposite order.

Blood tests later showed that those who slept five hours a night had a reduced sensitivity to insulin, which in time could increase the risk of getting diabetes.

But when they slept nine hours a night, oral insulin sensitivity returned to normal. Still, it wasn't enough time to restore intravenous insulin sensitivity to baseline levels.

"We did a study last year showing weight gain is caused by a lack of sleep and now we find that there could also be a risk of diabetes," said Eckel, an expert in diabetes, cardiology and atherosclerosis. "While the exact mechanisms are unknown, it's clear that a lack of sleep causes metabolic stress."

Wright, director of the Sleep and Chronobiology Laboratory, believes the answer could lay in our body clock.

"We have a clock in our brain which controls 24-hour patterns in our physiology and behavior. It also controls the release of the hormone melatonin which signals our body that it's night time," Wright said. "High melatonin levels at night tell us to sleep."

But if a person eats instead of sleeps during this time, it may alter the way the body responds to the food, impairing insulin sensitivity, he said.

"The body has to release more insulin to keep blood sugar levels normal," Wright said. "Our bodies can adapt initially but over the long term they may not be able to sustain it." Diabetes rates are skyrocketing nationwide, said Eckel. By 2050, he noted, as many as 33 percent of all Americans may have Type 2 diabetes.

"In this study we are dealing with healthy individuals," Eckel said. "I think the next step is to test those at a higher risk of diabetes."

Both researchers said the study involved a unique level of collaboration.

"Bob is a diabetes expert and I'm a sleep expert and we brought our expertise together here," Wright said. "This is a great example of collaborative science."
-end-
The study was funded by the National Institutes of Health and the Howard Hughes Medical Institute with the Biological Sciences Initiative/Undergraduate Research Opportunities Program at CU-Boulder. It appears online today in the journal Current Biology.

University of Colorado Anschutz Medical Campus

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.